Devyser Diagnostics AB (publ)
STO: DVYSR.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jan Wahlstrom
- Employees
- 120
- Headquarters
- Hägersten, Sweden
- IPO year
- 2021
- Market cap
- SEK 1.6B
- Website
- https://devyser.com
Loading DVYSR…
Loading profile data…Frequently asked questions about DVYSR
What does Devyser Diagnostics AB (publ) (DVYSR.ST) do?
Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation; thalassemi...
Where does DVYSR.ST trade?
Devyser Diagnostics AB (publ) (DVYSR.ST) trades on the Stockholm Stock Exchange.
What sector is DVYSR.ST in?
Devyser Diagnostics AB (publ) (DVYSR.ST) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Devyser Diagnostics AB (publ)?
Jan Wahlstrom is the chief executive officer of Devyser Diagnostics AB (publ) (DVYSR.ST).
Where is Devyser Diagnostics AB (publ) headquartered?
Devyser Diagnostics AB (publ) is headquartered in Sweden.
Does DVYSR.ST pay a dividend?
Devyser Diagnostics AB (publ) (DVYSR.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DVYSR.ST go public?
Devyser Diagnostics AB (publ) (DVYSR.ST) completed its initial public offering in 2021.